EUVIMEDEUVIMED entdecken
Crossref

P-510: Glycemic control in children and adolescents with type 1 diabetes: impact of disease duration and temporal trends in a resource-limited setting

P-510: Glykämische Kontrolle bei Kindern und Jugendlichen mit Typ-1-Diabetes: Einfluss der Erkrankungsdauer und zeitliche Trends in einer ressourcenarmen Umgebung

J Alencar Melo, G Vasconcelos Barros, A Liberal de Matos, M A Ramos Albuquerque, A B Oliveira Barbosa, C Donaire Sousa, P Padilha Ribeiro, B Gomes, A H Ferreira, J Araujo, T Andrade Schuler

Hormone Research in Paediatrics · 04.11.2026 · 99 (Supplement_4)

DOI: 10.1159/hrp/adaag020.565 ↗

Auf einen Blick

Bei 99 Kindern und Jugendlichen mit Typ-1-Diabetes war die glykämische Kontrolle über 3 Jahre schlecht. Mit längerer Krankheitsdauer nahm HbA1c zu; der Trend war jedoch nur über die Zeit signifikant.

Fragestellung

Zusammenhang zwischen Erkrankungsdauer und glykämischer Kontrolle sowie 3-Jahres-HbA1c-Trends bei Kindern und Jugendlichen mit Typ-1-Diabetes.

Methode

Retrospektive Analyse von Kindern und Jugendlichen mit Typ-1-Diabetes an einem öffentlichen Tertiärzentrum in Nordostbrasilien; HbA1c der letzten 3 Jahre; Vergleich nach Krankheitsdauer mit Kruskal-Wallis-Test, Jahresverlauf mit Friedman-Test.

Ergebnisse

99 Patient:innen, mittleres Alter 14,7 ± 2,9 Jahre. Mittleres 3-Jahres-HbA1c 9,60 % ± 1,69 %. 9,13 % ± 1,32 % (2-5 Jahre), 9,77 % ± 1,84 % (5-10 Jahre), 9,87 % ± 1,74 % (>10 Jahre; p=0,28). 2023: 9,16 %; 2026: 9,90 % (p=0,007).

Schlussfolgerung der Autor:innen

Jugendliche mit Typ-1-Diabetes in diesem ressourcenarmen Setting hatten anhaltend schlechte glykämische Kontrolle mit zunehmender Verschlechterung über die Zeit trotz Heim-Messung und fachärztlicher Nachsorge.

Kernaussagen

  • Mittleres 3-Jahres-HbA1c: 9,60 % ± 1,69 %
  • HbA1c stieg mit Krankheitsdauer, ohne Signifikanz (p=0,28)
  • Jahresmittel-HbA1c verschlechterte sich von 2023 bis 2026 (p=0,007)

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Hormone Research in Paediatrics, online erschienen am 04.11.2026. Verfasst von J Alencar Melo und 10 weiteren Autor:innen.

Auf einen BlickAbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In Northeast Brazil, socioeconomic vulnerability and limited access to diabetes resources remain major barriers to optimal T1D care. Pediatric patients with T1D often have inconsistent access to essential supplies and specialized education, which may compromise long-term outcomes.

Objectives

To evaluate the association between disease duration and glycemic control, and to assess 3-year HbA1c trends in a real-world pediatric cohort.

Methods

We retrospectively analyzed children and adolescents with T1D followed at a public tertiary center in Northeast Brazil who attended clinic over a 3-month period (January-April 2026). Glycemic control was assessed using HbA1c values from the previous 3 years. Patients were stratified by disease duration into 2-5 years, 5-10 years, and >10 years. The 3-year mean HbA1c was compared using the Kruskal-Wallis test, and annual HbA1c progression was assessed using the Friedman test.

Results

Ninety-nine patients were included (mean age 14.7 ± 2.9 years, range 6.9-18.7); all performed home capillary glucose monitoring. Overal, 92% were treated with insulin analog-based regimens, and 8% NPH plus regular insulin. The overall mean 3-year HbA1c was 9.60% ± 1.69%. Mean HbA1c increased by 0.74% between the shortest and longest disease-duration groups, although this was not statistically significant (9.13% ± 1.32% for 2-5 years, 9.77% ± 1.84% for 5-10 years, and 9.87% ± 1.74% for >10 years; p=0.28). In contrast, longitudinal analysis showed significant worsening in annual mean HbA1c from 9.16% in 2023 to 9.90% in 2026 (p=0.007).

Conclusions

Youth with T1D in this resource-limited setting had persistently poor glycemic control, with progressive deterioration over time despite home monitoring and specialist follow-up. These findings may reflect the combined effects of puberty, evolving self-management responsibilities, and structural barriers to care, highlighting the need for long-term, context-adapted educational strategies.

Zitieren

APA

Melo, J. A., Barros, G. V., Matos, A. L. D., Albuquerque, M. A. R., Barbosa, A. B. O., Sousa, C. D., Ribeiro, P. P., Gomes, B., Ferreira, A. H., Araujo, J., & Schuler, T. A. (2026). P-510: Glycemic control in children and adolescents with type 1 diabetes: impact of disease duration and temporal trends in a resource-limited setting. Hormone Research in Paediatrics, 99(Supplement_4). https://doi.org/10.1159/hrp/adaag020.565

Vancouver

Melo JA, Barros GV, Matos ALD, Albuquerque MAR, Barbosa ABO, Sousa CD, et al. P-510: Glycemic control in children and adolescents with type 1 diabetes: impact of disease duration and temporal trends in a resource-limited setting. Hormone Research in Paediatrics. 2026;99(Supplement_4). doi:10.1159/hrp/adaag020.565

BibTeX
@article{Melo2026,
  author = {Melo, J Alencar and Barros, G Vasconcelos and Matos, A Liberal de and Albuquerque, M A Ramos and Barbosa, A B Oliveira and Sousa, C Donaire and Ribeiro, P Padilha and Gomes, B and Ferreira, A H and Araujo, J and Schuler, T Andrade},
  title = {P-510: Glycemic control in children and adolescents with type 1 diabetes: impact of disease duration and temporal trends in a resource-limited setting},
  journal = {Hormone Research in Paediatrics},
  year = {2026},
  volume = {99},
  number = {Supplement_4},
  doi = {10.1159/hrp/adaag020.565}
}
Kostenlos starten →